Codex
Codexis (CDXS) got here out with quarterly earnings of $0.02 per share, lacking the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.03 per share a yr in the past. These figures are adjusted for non-recurring objects.
This quarterly report represents an earnings shock of -66.67%. 1 / 4 in the past, it was anticipated that this producer of customized industrial enzymes would put up a lack of $0.06 per share when it truly produced earnings of $0.04, delivering a shock of 166.67%.
During the last 4 quarters, the corporate has surpassed consensus EPS estimates two occasions.
Codexis, which belongs to the Zacks Medical – Biomedical and Genetics business, posted revenues of $18.65 million for the quarter ended December 2019, lacking the Zacks Consensus Estimate by 11.41%. This compares to year-ago revenues of $16.07 million. The corporate has topped consensus income estimates two occasions over the past 4 quarters.
The…